Skip to content

Application value of dynamic lung function monitoring in asthma diagnosis and treatment

Application value of dynamic lung function monitoring in asthma diagnosis and treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027843
Enrollment
Unknown
Registered
2019-11-30
Start date
2020-01-01
Completion date
Unknown
Last updated
2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchial asthma

Interventions

control:Routine outpatient visits
intervention group:Dynamic lung function monitoring

Sponsors

Tianjin First Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 70 Years

Inclusion criteria

Inclusion criteria: The chief complaint is recurrent cough, chest tightness or wheezing; The X-ray normal; Aged > 15 years old and < 70 years old of non-pregnancy; Be able to use the handheld lung function meter correctly after professional instruction; Can use smart phone and WeChat software; The patient agreed to participate in the study and signed the informed consent form.

Exclusion criteria

Exclusion criteria: Cough, chest tightness or wheezing caused by other diseases (such as chronic bronchitis, upper respiratory tract infection, lung infection, cardiac insufficiency, lung tumor, etc.. Combined with other systemic diseases (such as severe liver and kidney dysfunction, nervous system diseases, etc.. Patients with acute exacerbation of respiratory symptoms. Severe cognitive impairment or mental disorders are not compatible with clinical studies. Pneumothorax giant lung bulges and do not prepare for surgical treatment, pregnancy patients, such as carefully do forced exhalation of lung function examination. A woman of child-bearing age who is pregnant or preparing for pregnancy. Participated in other drug clinical trials within the last three months. Patients with myocardial infarction or shock within the last three months, severe cardiac instability, angina pectoris, massive hemopsis, epileptic dyffa within the last four weeks, uncontrolled hypertension (systolic blood pressure > 200mmHg, diastolic blood pressure > 100mmHg), heart rate > 120 times /min, aortic aneurysm patients and other contractile lung function examination. Patients with perforated eardrums.

Design outcomes

Primary

MeasureTime frame
PEF???;PEF%;

Secondary

MeasureTime frame
FVC%;FEV1%;FEV1/ FVC%;ACT??;

Countries

China

Contacts

Public ContactPing Jiang

Respiratory Department, Tianjin First Central Hospital

jiangping030@sina.com+86 13502099736

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026